Exxel Pharma Inc. (EXXL)

Exxel Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2024	Dec 31, 2023
Debt / Equity Ratio	-0.65	-0.45	-
Debt / EBITDA Ratio	-1.69	-1.48	-
Debt / FCF Ratio	-1.84	-1.43	-
Net Debt / Equity Ratio	-0.48	-0.06	0.28
Net Debt / EBITDA Ratio	-1.25	-0.20	0.56
Net Debt / FCF Ratio	-1.36	-0.19	0.60
Quick Ratio	0.14	0.27	0.21
Interest Coverage	-4.85	-12.17	-
Return on Equity (ROE)	58.16%	35.69%	50.22%
Return on Assets (ROA)	-	-80.82%	-143.37%
Return on Capital Employed (ROCE)	41.08%	32.98%	50.22%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).